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Abstract
Background: Admission hyperglycemia (HG) has been associated with worse outcomes among acute stroke
patients. A better understanding and awareness of the potentially adverse influence of hyperglycemia on the
clinical outcome of acute stroke patients would help to provide guidance for acute stroke management and
prevention of its adverse outcomes. We aimed to assess the frequency of admission hyperglycemia and its impact
on short term (30-days) morbidity and mortality outcomes of stroke in adult Ethiopian patients in an urban setting.
Methods: A prospective, cross-sectional study was conducted among acute stroke patients admitted to Tikur Anbessa
Specialized Hospital (TASH), within 72 h of symptom onset, from July to December 2016. Socio-demographic data,
neuroimaging findings and capillary blood glucose values were obtained on admission. Hyperglycemia was defined as
> 140mg/dl. National Institute of Health Stroke Scale (NIHSS) and modified Rankin Scale (mRS) were used to assess the
baseline stroke severity and the 30-days post-stroke outcome, respectively.
Results: A total of 103 first-ever acute stroke patients were included (mean age = 55.5 + 15.3 years, 64.1% male and
65% under the age of 65 years) and 51 (49.5%) were hyperglycemic at time of admission. The median admission NIHSS
score was worse in the hyperglycemic patients 14 (IQR 10–19) compared to normoglycemic patients 11 (IQR 8–15).
Among stroke survivors, patients with hyperglycemia were 3.83 times (95% CI, 1.99–6.19) more likely to be functionally
impaired (mRS = 3–5) at 30-days compared to normoglycemic patients (P = 0.041).Older age (≥ 65 years) (P = 0.017)
and stroke severity (NIHSS > 14) (P = 0.006) at admission were both significantly associated with poor functional
recovery at 30-day. Among patients who died at 30-day, two-third (66.7%) were hyperglycemic but they failed to show
any significant association.
Conclusions: Hyperglycemia is prevalent among Ethiopian stroke patients at the time of presentation and it is
associated with significantly poor functional recovery at 30th-day of follow up. This finding provides a rationale for
achieving normal blood glucose in the course of acute stroke management which could have a favorable impact on
the neurological outcome and quality of life for patients.
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Background
Stroke remains a major global health problem, ranking the
second most common cause of death and the third cause
of disability worldwide [1]. Report from the 2013 Global
Burden of Disease study showed that the absolute num-
bers of people affected by stroke every year, and lived with
the consequence of stroke or died from their stroke, had
increased significantly between 1990 and 2013 around the
world. In 2013 globally there were 25.7 million stroke
survivors, 6.5 million deaths from stroke, 113 million
disability-adjusted life years (DALYs) due to stroke and
10.3 million new strokes. It was also found that the preva-
lence for both ischemic and hemorrhagic stroke nearly
doubled across the globe over this period [2].
Although stroke related death and DALY rates have de-
clined in both developed and developing countries over
the past several decades, there is a significant increase in
the absolute numbers of stroke deaths among younger
adults aged between 20 and 64 years in developing coun-
tries, where the preponderance of the burden of stroke
continued to reside and contributing 75.2% of deaths from
stroke and 81.0% of stroke-related DALYs [1, 2].
In the past few years, developing countries including
Sub-Saharan Africa (SSA) are exhibiting rapid
urbanization and epidemiological transition with a sharp
rise in the population number and life expectancy as well
as changing lifestyle and a dietary habit which will increase
the risk of cardiovascular disease, particularly stroke [3].
This changes in combination with poor health care service
and lack of government commitment will contribute to a
looming epidemic of stroke in the SSA regions.
Stroke patient’s outcome is influenced by a myriad of
factors, including stroke subtype, stroke severity, associ-
ated comorbidities (prior history of diabetes mellitus
(DM) or hypertension), post-stroke complications, and
availability of acute stroke care facilities [4]. Admission
hyperglycemia (HG) is one of the potentially modifiable
factors associated with adverse stroke outcomes [5].
Several clinical and experimental studies have shown
that admission hyperglycemia has a deleterious effect on
short term outcomes of acute stroke patients, although
some other studies have presented conflicting data [6,
7]. Elevated blood glucose during the acute phase of
stroke is not always due to underlying diabetes mellitus
and may be due to a stress-induced high cortisol
response. However, the notion of causality from hyper-
glycemia or a consequence of more severe stroke
remains controversial [6, 8].
There is a higher percentage of in-hospital case fatality
and severe neurologic deficits among acute stroke pa-
tients admitted to tertiary care hospitals in Ethiopia as
compared to the global average [9]. Little is known,
however, about the relationship between admission
hyperglycemia and stroke outcomes in SSA, particularly
in the east Africa countries, where the number of neu-
rologists is limited and access to stroke centers is negli-
gible. So far there is no published data that has assessed
the deleterious effect of high blood glucose on stroke
patients’ outcomes in the region. The aim of this first
prospective study among Ethiopian stroke patients was
to assess the point-prevalence of admission hypergly-
cemia and its impact on short term neurological recov-
ery and case fatality. We hypothesized that a high
frequency of admission hyperglycemia and less favorable
functional recovery with increased mortality rate would
be seen in a cohort of Ethiopian stroke patients at
thirty-days of follow up.
Methods
Study design
An institution based prospective, cross-sectional study
was conducted at Tikur Anbessa Specialized Hospital
(TASH) between July and December, 2016.
Study setting
TASH is located in Addis Ababa, the capital of Ethiopia. It
is the largest and the first tertiary level referral university
teaching hospital with an estimated bed capacity of over
700. It has an emergency unit, an intensive care unit, a
neurology ward, a clinical laboratory, and a radiology
department with a Computerize Tomography (CT) and
Magnetic Resonance Imaging (MRI) services. There is an
integrated clinical service composed of highly trained
neuro-radiologists, neurologists and emergency care phy-
sicians who serve for the entire nation.
Study population
The study population was all patients presenting to the
emergency department with neurologic deficits suggest-
ive of acute stroke and who fulfilled the inclusion criteria
of age greater than 14 years, presentation within 72 h of
symptom onset, and confirmation of stroke diagnosis
using emergency brain CT scan. A non-fasting capillary
blood sample was used to estimate the admission blood
glucose (BG) using a calibrated glucometer. Exclusion
criteria were: age less than 14 years, patients with clinical
course consistent with transient ischemic attack (TIA),
trauma related cerebral hemorrhage, subarachnoid
hemorrhage, prior neurologic deficit, prior stroke, un-
known duration from symptom onset and who declined
to give consent.
Sample size and sampling technique
The sample size was calculated using the single popula-
tion proportion formula n = Z α 2*pq/d2 = 164 with esti-
mated population proportion of 30% [10], α = 5% and
d = 5%. During the study period, all first-ever acute
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stroke patients who met the inclusion criteria were en-
rolled consecutively.
Baseline data collection
The socio-demographic and clinical data were collected
using a structured questionnaire that was pre-tested in 8
acute stroke patients having weakness on the non-
dominant side and we got a complete response. We
attempted to mitigate selection bias by randomizing par-
ticipant selection using the same inclusion criteria detailed
above. The National Institute of Health Stroke Scale
(NIHSS) was used to measure the stroke severity. NIHSS
is a 15-item neurologic examination stroke scale that sums
the scores from individual elements to provide an overall
stroke impairment score. It is a well-validated and com-
monly used assessment tool to evaluate the baseline
neurologic deficit in acute stroke patients. The NIHSS
score was dichotomized into: mild stroke (NIHSS score ≤
14) and severe stroke (NIHSS score > 14) [11].
In all patients, BG was documented and hyperglycemia
was defined as BG level ≥ 140mg/dl and normoglycemia
as BG < 140mg/dl [12]. DM was diagnosed if the patient
had a pre-existing diagnosis of DM or was taking anti-
diabetics drugs before stroke onset. If the BG was > 200
mg/dl and a repeat Fasting blood glucose (FBG) test
showed ≥126mg/dl, then patients were classified as newly
diagnosed DM based on ADA diagnostic criteria [13].
Thirty-day outcome
The modified Rankin Scale (mRS) was used for the as-
sessment of functional outcome at 30-day after the index
stroke onset, which may coincide with the time of hos-
pital discharge and for those who were discharged earl-
ier, we followed them by telephone using standardized
interview protocol. The mRS is six-point ordinal scale
ranging from 0 (no symptoms) to 6 (death) measuring
the degree of disability or dependence in everyday life,
including instrumental and basic activities of daily living
(ADL). The functional mRS scoring was subcategorized
into; good outcome (independence in ADL, mRS score
(0–2), and poor outcomes (dependence in ADL, mRS
score 3–5). A mRS score of 6 signifies a patient death
(30-day mortality) [14].
Statistical analysis
Data were analyzed using the Statistical Package for Social
Sciences version 20.0 software package (SPSS Inc., Chi-
cago, IL, USA). Descriptive statistics were summarized
using the frequency and proportion table for categorical
data and mean (standard deviation) or median (interquar-
tile range) for continuous data. The Pearson’s Chi square
test were used to compare noncontinuous data. For
dichotomous data, multiple logistic regression models
were used to determine univariate and multivariate
associations between 30-day outcomes and patient related
variables including; demographic factors; prior history of
DM; type of stroke based on neuroimaging findings;
stroke severity by NIHSS and BG category. Adjusted odds
ratios with 95% confidence interval (CI) were estimated.
Level of statistical significance was set at P < 0.05.
Ethics approval and consent to participate
Ethics approval was obtained from the Institutional
Review Board (IRB) of College of Health Science in
Addis Ababa University. A written informed consent
was obtained from each patient when clinically appropri-
ate. For patients with depressed consciousness or severe
aphasia, written consent was obtained from their care
takers. For participants aged 14–18 years, an assent form
was obtained from their parents or legal guardians. Con-
fidentiality and anonymity of all patient data were kept
throughout the study. The study was performed in
accordance with the Declaration of Helsinki.
Results
Socio-demographic characteristics
We approached 110 first-ever acute stroke patients, of
whom 7 were excluded due to incomplete NIHSS data
during hospitalization. The remaining 103 stroke patients
were included in the final analysis having a mean age + SD
of 55.5 + 15.3 years at presentation. The majority (64.1%)
were male and around two-third (65%) were under the
age of 65 years. Among our study participants, 82 (79.6%)
were married and 8 (7.8%) were single. Thirty-two (31.1%)
patients were farmers by occupation and 41 (39.8%) were
illiterates with no formal education. Findings on initial
brain CT scan classified stroke subtypes as 52 (50.5%)
cases of ischemic and 51 (49.5%) hemorrhagic stroke
cases. In 8 (7.8%) of the participants the diagnosis of dia-
betes was known before the stroke onset. While 7 of our
patients had a BG > 200mg/dl at presentation, three
(2.9%) of them fulfilled the ADA diagnostic criteria [13]
for a newly diagnosed DM after the stroke onset. Table 1
summarizes the socio-demographic and clinical character-
istics of the participants.
Relationship between admission blood glucose level and
clinical characteristics
Almost half (49.5%) of our study participants were
hyperglycaemic at the time of admission with a BG
level ≥ 140 mg/dl. The mean (+ SD) BG level in the
normoglycemic and hyperglycemic groups were
119.9 + 13.0 mg/dl and 183.2 + 34.5 mg/dl, respectively.
Admission hyperglycemic was presented in the majority
7/8 (87.5%) of diabetic patients and a multiple regression
analysis showed that diabetes diagnosed before or after
the stroke onset was related to high admission blood
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glucose level independent of age, sex, stroke subtype and
baseline stroke severity (P = 0.023).
The median NIHSS score was higher in the hypergly-
cemic (BG) patients (14 [IQR 10–19]) as compared to the
normoglycemic patients (11 [IQR 8–15]). But a multiple
regression analysis showed there was no relationship
between BG and stroke severity on admission NIHSS in-
dependent of age, sex, diagnosis of diabetes and stroke
subtype (P = 0.42).
Among the study participants, hemorrhagic stroke was
significant increased in patients with admission hyper-
glycemia (n = 33 (64.7%) vs n = 18 (35.3%); P = 0.002)
when compared to those with normal blood glucose
level on admission. The association between admission
blood glucose and clinical characteristics of the partici-
pants are shown in Table 2.
Thirty-day functional recovery and mortality in relation to
hyperglycemia and clinical characteristics
Among our stroke cohorts, the mean mRS score at 30-
day was 3.6 + 1.45. Ninety-one patients (88.3%) had sur-
vived until 30th-day and majority (70.3%) of them
showed poor functional recovery (mRS 3–5), while 27
(29.7%) patients had a good functional outcome (mRS
0–2). The association between clinical characteristics
and 30-day functional outcome among survivors are
shown in Table 3.
The functional recovery of stroke survivors at 30-days
were compared across the different clinical and labora-
tory profiles. Accordingly, a multivariate logistic regres-
sion analysis showed patients with high blood glucose
level at admission were 3.83 times (95% CI, 1.99–6.19)
more likely to be functionally impaired (mRS = 3–5) at
30th-day compared to those with normal glucose (P =
0.041). The other factors that were significantly associ-
ated with poor functional outcome were older age (≥ 65
years) at time of stroke onset (OR 5.53; 95% CI,1.36–
22.43; P = 0.017) and severe stroke (NIHSS > 14) (OR
0.12; 95% CI, 0.03–0.54; P = 0.006) at admission.
The 30-day mortality rate was 11.7% with a mRS score
of 6. Mortality was significantly increased in patients
younger than 65 years of age at time of stroke onset (P =
0.04) and severe stroke (NIHSS > 14) at time of
hospitalization (P = 0.004). Although 15.7% of hypergly-
cemic patients died at 30-day, on multiple logistic regres-
sion no significant difference was found from
normoglycemic patients (P = 0.94), after adjusting for age,
sex, stroke type and severity (see Table 4).
Discussion
We performed this prospective cross-sectional study to
determine the frequency of hyperglycemia and its effect
on the short-term outcome of acute stroke patients in a
resource limited setting where there are neither stroke
units nor comprehensive rehabilitation centers exist.
The majority of our participants were males with M:F
ratio of 1.8:1, and two-third of them were younger than
65 years with the mean age of 55.5 + 15.3 years at pres-
entation. This is similar to previous studies in Ethiopia
[15] and other studies in Africa [16, 17]. However, the
Table 1 Socio-Demographic and Clinical Characteristics of
acute stroke patients admitted to Tikur Anbessa Specialized
Hospital in Addis Ababa, Ethiopia
Variables Number Percentage (%)
Age (mean + SD), years 55.5 + 15.3
Age groups
< 65 years 67 65.0










Elementary school 39 37.8
High school 13 12.6









Ischemic stroke 52 50.5
Hemorrhagic stroke 51 49.5
Diabetes mellitus (DM)
No DM diagnosis 92 89.3
Previously diagnosed DM 8 7.8
Newly diagnosed DM 3 2.9
Admission NIHSS score
NIHSS ≤14 62 60.2
NIHSS > 14 41 39.8
mRS score at 30th day
mRS < 3 27 26.2
mRS ≥3 76 73.8
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Table 2 Factors associated with development of hyperglycemia at time of admission among acute stroke patients admitted to Tikur
Anbessa Specialized Hospital in Addis Ababa, Ethiopia
Variable Hyperglycemia (N = 51), (%) Normoglycemia (N = 52) (%) Adjusted OR (95% CI) P-value
Age
< 65 years 32 (47.7) 35 (52.3) 1.37 (0.52–3.62) 0.53
≥ 65 years 19 (52.7) 17 (47.3) 1
Gender
Male 33 (50.0) 33 (50.0) 0.83 (0.33–2.06) 0.68
Female 18 (48.6) 19 (51.4) 1
Diagnosis of diabetes mellitus
Yes 7 (87.5) 1 (12.5) 0.07 (0.01–0.69) 0.023
No 44 (46.3) 51 (53.7) 1
Type of stroke
Ischemic 18 (34.6) 34 (65.4) 1
Hemorrhagic 33 (64.7) 18 (35.3) 4.24 (1.67–10.76) 0.002
Admission NIHSS score
NIHSS > 14 25 (61.0) 16 (39.0) 1.53 (0.55–4.21) 0.42
NIHSS≤ 14 26 (41.9) 36 (58.1) 1
Median admission NIHSS (IQR) 14 (10–19) 11 (8–15)
Mean BG + SD (mg/dl) 183.2 + 34.5 119.9 + 13.0
Mean mRS + SD 3.82 + 1.34 3.33 + 1.52
Table 3 Factors associated with 30th day poor functional outcome among stroke survivors who were admitted to Tikur Anbessa
Specialized Hospital in Addis Ababa, Ethiopia
Variables 30th day functional outcome among survivors n = 91 Adjusted OR
(95% CI)
P-value
mRS 0–2 (n = 27,29.7%) mRS 3–5 (n = 64,70.3%)
Age
< 65 years 22 (81.5) 34 (60.7) 1
≥ 65 years 5 (14.3) 30 (85.7) 5.53 (1.36–22.43) 0.017
Gender
Male 17 (29.3) 41(70.7) 0.99 (0.34–2.88) 0.98
Female 10 (30.3) 23 (69.7) 1
History of diabetes mellitus
Yes 1 (12.5) 7 (87.5) 0.29 (0.02–3.97) 0.35
No 26 (31.3) 57 (68.7) 1
Admission Blood glucose level
≥ 140mg/dl 9 (20.9) 34 (79.1) 3.83 (1.99–6.19) 0.041
< 140mg/dl 18 (37.5) 30 (62.5) 1
Type of stroke
Ischemic 18 (36.0) 32 (64.0) 3.52 (0.96–12.94) 0.058
Hemorrhagic 9 (21.9) 32 (78.1) 1
Admission NIHSS score
NIHSS > 14 3 (9.7) 28 (90.3) 0.12 (0.03–0.54) 0.006
NIHSS≤ 14 24 (40.0) 36 (60.0)
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average age of our stroke patients was younger than
stroke victims in western countries. The median age re-
ported by the European Registers of Stroke was 73 years
[IQR 62 to 81] [18].
We found an equal proportion of ischemic (50.5%)
and hemorrhagic strokes (49.5%) with 1.02:1 ratio. How-
ever, a higher proportion of ischemic stroke had been
reported by other African countries [16, 17] in accord-
ance with the western epidemiology [19]. Our result is
similar to prior hospital-based studies in Ethiopia (1.72:
1) [15] and (1.01:1) [20]. The possible explanation for
the equal proportion of ischemic and hemorrhagic
stroke in our setup may be related to the study setting,
where most minor ischemic strokes and TIA’s were
treated at the primary care centers with spontaneous
resolution of clinical symptoms and minor disabilities
that did not necessitate referrals to a tertiary care center
like ours.
We have shown a high prevalence (49.5%) of hypergly-
caemia in patients presenting with acute stroke to a hos-
pital. This observation is consistent with several other
studies in which the reported prevalence of admission
hyperglycemia in acute stroke patients varied from 20 to
50%, depending on the study design (prospective or
retrospective), the cut off value for hyperglycemia and
stroke subtype [12, 21]. A 28% prevalence rate was re-
ported by Ogunrin et al. [22], using the same hypergly-
cemic definition (≥140 mg/dl) from west Africa, Nigeria.
But the authors attributed the lower prevalence to the
retrospective design of their study and that might have
affected their results, as only 100 of their 163 patients
had blood glucose estimated at admission.
Diabetes mellitus is a well-recognized risk factor for
stroke and the frequency of diabetes in our study was
10.7%. This finding is slightly higher than the preva-
lence of DM across different localities of Ethiopia, 0.3
to 7.0% [23]. We found a 2.9% prevalence of newly di-
agnosed diabetes which probably reflect the prevalence
of undiagnosed diabetes in acute stroke population at
time of hospitalization, although geographical variations
noted. A comparable frequency of 5.3% was reported by
Woo J and his colleagues, from a regional general hos-
pital in Hong Kong [24]. While a higher 11% prevalence
was reported by L.S. Williams et al. [25]. A study from
USA showed a short median time between the onset of
diabetes and stroke and a high incidence of newly-
diagnosed diabetes in acute stroke patients could be ex-
pected [26]. These findings support the importance of
screening all acute stroke patients for undetected dia-
betes and confirm the diagnosis by determining the
fasting plasma glucose or glycated hemoglobin (HbA1c)
level, especially if the admission glucose level was very
high (> 200 mg/dl).
In this study, the median NIHSS score at admission
was higher (14) in the hyperglycemic group as com-
pared to (11) normoglycemic group. But on multiple lo-
gistic regression, we found no significant difference on
stroke severity (NIHSS > 14) between the two groups
after adjusting for age, sex, diabetes history and stroke
type. In the contrary, Stead and his colleagues reported
Table 4 Factors associated with 30 -day mortality among stroke patients admitted to Tikur Anbessa Specialized Hospital in Addis
Ababa, Ethiopia
Variables Patients’ condition at 30th day Adjusted OR
(95% CI)
P-value
Died (mRS = 6) n = 12, 11.7% Alive (mRS < 6) n = 91, 88.3%
Age
< 65 years 11 (16.4) 56 (83.6) 0.05 (0.003–0.83) 0.04
≥ 65 years 1 (2.8) 35 (97.2) 1
Gender
Male 8 (12.1) 58 (87.9) 1.1 (0.18–6.89) 0.92
Female 4 (10.8) 33 (89.2) 1
Admission Blood glucose level
≥ 140mg/dl 8 (15.7) 43 (84.3) 0.96 (0.15–6.36) 0.97
< 140mg/dl 4 (7.7) 48 (92.3) 1
Type of stroke
Ischemic 2 (3.8) 50 (96.2) 1
Hemorrhagic 10 (19.6) 41 (80.4) 4.62 (0.34–63.15) 0.25
Admission NIHSS score
NIHSS > 14 10 (24.4) 31 (75.6) 0.039 (0.004–0.38) 0.004
NIHSS≤ 14 2 (3.2) 60 (96.8) 1
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strong association between hyperglycemia and sever
stroke at presentation [27].
Our patients with hyperglycemia had a significant
disability with poor functional recovery (mRS ≥3) at
30-day. This finding is in line with hospital-based re-
port among ischemic stroke patients in China, where
hyperglycemia was identified as an independent pre-
dictor for a poor functional outcome (defined as mRS
≥3), at 30 and 90 days after the stroke onset [28]. Sun
et al. [29] analyzed a large cohort of patients with in-
tracerebral hemorrhage, which showed an elevated ad-
mission blood glucose was an independent predictor
of 3-month poor outcome and they concluded that
hyperglycemia has a greater prognostic value in non-
diabetics than diabetics with a similar glucose level. A
possible explanation for the negative association be-
tween hyperglycemia and poor functional outcomes
after a stroke includes direct toxic effect of high
blood glucose to ischemic neurons which may disrupt
the blood-brain barrier and promote hemorrhagic in-
farct conversion [28] and also increasing superoxide
production may exacerbate perihematomal cell death
in the brain [29].
Stroke severity at admission was also significantly
associated with poor functional outcome and in-
creased risk of death at 30 days. Green SR et al. [8]
compared 103 acute ischemic stroke patients based
on their admission blood glucose level and they found
a similar association, where functional outcomes at
30- and 90-day were poor among the diabetics and
stress hyperglycemic groups who also had a higher
NIHSS score of > 13 at admission These findings pos-
sibly explained by the prolonged hospital stay, severe
motor weakness and a higher rates of medical compli-
cations that follows severe stroke.
Multiple studies [6, 12, 29] showed the relationship
between high admission blood glucose and short term
mortality among acute stroke patients at different time
periods after stroke onset. However, in this study ma-
jority (66.7%) of the patients died at 30-day were hyper-
glycemic at admission but they failed to show the
expected negative associations. This discrepancy could
be explained by the small number of participants and
those patients with severer stoke were possibly died be-
fore reaching the hospital. Several limitations must be
acknowledged. First, the diagnosis of DM was based
only on medical. history and FBG test where confirma-
tory tests like HbA1c were not done to exclude stress
hyperglycemia. Second, a single-center, hospital-based
study in an urban setting might introduce. selection
bias and likely to overrepresent the more severe stroke
cases referred for tertiary care. Therefore, we acknow-
ledge the limited generalizability of our findings to the
general population.
Conclusion
Our analysis showed a higher prevalence of hypergly-
cemia in Ethiopian acute stroke patients at presentation
and it had a significant association with poor functional
recovery at short-term. The negative impact of admis-
sion hyperglycemia on functional recovery suggests that
achieving normal blood glucose in the early stages of
stroke may favorably influence the clinical recovery and
quality of life of the patients. Further studies with a
larger cohort in a multi-center setting are required to
determine the independent role of hyperglycemia in
neurological outcomes in stroke patients.
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